The aim of this study is to assess the efficacy of injecting steroid into the carpal tunnel in relieving symptoms of carpal tunnel syndrome for at least 1 year with outcomes measured with patient evaluated symptoms score.Out of the patients referred by primary care, those with a clinical diagnosis of CTS who have tried wrist splint and whose symptom severity is judged by the examining surgeon to warrant surgery are offered to be put on the waiting list for carpal tunnel release. This means a waiting time of approximately 3 months. Patients who give informed consent will be asked to attend the outpatient clinic for a physical examination followed by allocation to one of the three trial groups. Immediately following the allocation the patients will receive the assigned treatment.
www.biomedcentral.com/1471-2474/11/76
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
112
Depo-medrol 40 mg , suspension, injection in the carpal tunnel, one time use 1 ml 40 mg Methylprednisolone + 1 ml 10mg Lidocaine + 1 ml saline
Depo-medrol 80 mg , suspension, injection in the carpal tunnel, one time use. 2 ml 80mg Methylprednisolone + 1 ml 10mg Lidocaine
Saline solution 0,9%, injection in the carpal tunnel, one time use 1 ml 10 mg Lidocaine + 2 ml saline
Ortopediska kliniken, sjukvårdsorganisationen Hässleholm/CSK
Hässleholm, Sweden
The CTS symptom severity score after treatment.
Time frame: 10 weeks
Rate of surgery
Time frame: 52 weeks
The CTS symptom severity score after treatment
Time frame: 52 weeks
Time to surgery
Time frame: 52 weeks
QuickDASH score
Time frame: 52 weeks
SF-6D score
Time frame: 52 weeks
Patient satisfaction with the results of treatment (VAS scale)
Time frame: 52 weeks
Registration of adverse events
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.